IL1B and Kawasaki disease: Moreover, previous studies have provided strong evidence that IL-1β plays a pivotal role in the pathogenesis of coronary lesions in a mouse model of Kawasaki disease (KD), which can be effectively inhibited by IL-1 receptor antagonists (35).